Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.36 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.36 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 3/20 | 0.35 |
| ▸ | BAD | Q92934 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27899 | 1.00 | ABCG2 (0.39) | ABCG2CYP3A4TDP1TXNRD1TXNRD3 | |
| SCHEMBL29352284 | 1.00 | ABCG2 (0.39) | ABCG2CYP3A4TDP1TXNRD1TXNRD3 | |
| SCHEMBL6904608 | 0.98 | ABCG2 (0.38) | ABCG2CYP3A4TDP1TXNRD1TXNRD3 | |
| SCHEMBL16449681 | 0.91 | NQO2 (0.34) | ABCG2CYP3A4TDP1TXNRD1TXNRD3 | |
| Acetic Acid SCHEMBL29761322 | 0.91 | NPC1 (0.35) | CYP3A4TDP1TXNRD1TXNRD3TXNRD2 | |
| SCHEMBL17758851 | 0.89 | DRD1 (0.32) | ABCG2TXNRD1TXNRD3TXNRD2CYP1A2 | |
| SCHEMBL13695077 | 0.89 | AOC3 (0.37) | ABCG2TDP1TXNRD1TXNRD3TXNRD2 | |
| SCHEMBL29365010 | 0.86 | ITGB2 (0.39) | CYP3A4TDP1DRD1MAOBPKM | |
| SCHEMBL1203836 | 0.86 | ITGB2 (0.39) | CYP3A4TDP1DRD1MAOBPKM | |
| SCHEMBL5684662 | 0.85 | ABCG2 (0.38) | ABCG2CYP3A4TDP1TXNRD1TXNRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2123357-B1 | CYANATION CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANHYDRIN COMPOUND USING THE SAME | UNIV HOKKAIDO NAT UNIV CORP (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-8163947-B2 | Cyanation catalyst and method for producing optically active cyanhydrin compound using the same | NATIONAL UNIVERSITY CORPORATION, HOKKAIDO UNIVERSITY (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20100029977-A1 | CYANATION CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANHYDRIN COMPOUND USING THE SAME | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2123357-A1 | CYANATION CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANHYDRIN COMPOUND USING THE SAME | National University Corporation Hokkaido University (JP) | 2009-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029977-A1 | CYANATION CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANHYDRIN COMPOUND USING THE SAME | TYR, IK, CYB5R3 | ABCG2 848/4885CYP3A4 217/4885TDP1 4152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.